MedTech Equipment Consulting


Hospital systems and physicians globally have continued to face increasing pressures around MedTech equipment related to budgets and technology. Investing in the most advanced equipment is a significant capital outlay and hospitals are forced to weigh this investment against the ability to attract new patients, increase throughput and improve outcomes. Consequently, MedTech companies are being forced to be strategic about product introductions and be creative with purchasing options while continuing to stay on the cutting edge of technological advancements. AKTCG has extensive experience across equipment types, including imaging, monitoring and ventilation equipment. We have continually assisted our MedTech clients in navigating these changing markets and in developing strategies that maximize patient and physician benefit while maximizing their own value

Client Issues

Our MedTech clients rely on our extensive experience and ability to draw important insights from analysis in this space and answer their most important questions, such as:

  • How will this market evolve over the next 3-5 years based on new technologies entering the market?
  • How will changes to healthcare systems impact physicians’ ability to utilize our products?

Examples of Our Work

To learn more about how we help our clients create value, please refer to these case examples:

  • A large, multinational healthcare company wanted to undertake a systematic and methodologically sound data collection that builds an externally validated projection of the MRI business.  AKTCG produced a robust and rigorous modeling methodology focused on customers’ future purchasing plans, yielding a forecast with insights into the future MRI environment.
  • Our client enlisted our help in building a robust view of the structure and segmentation of the fast-evolving pathology-equipment market and an understanding of the decision-making processes for healthcare, hospital and diagnostic-pathology services in general. The client required these insights in order to identify the most suitable business models and service solutions in China. Leveraging our experience,AKTCG analyzed China’s remote pathology-services market and developed alternative business models based on patient volumes, available resources and the current pathology capabilities of different hospital tiers.

Please contact us at for additional information.